Trial
NCT00684164
Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Columbia University
Collaborators
Astellas Pharma Inc
Condition
Hyponatremia
Intervention
Conivaptan
Why stopped
Unable to complete a contract with the Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-06